Accrued Revenue: The Ultimate Cash-Sucker

Hope you had a great week! Last week we discussed deferred revenue and why we should understand it. This week we’re examining its evil cousin: accrued revenue. There’s a lot in common. But here’s the key difference:

    • Deferred Revenue = job not complete but cash received
    • Accrued Revenue = job complete but cash not received

Alright let’s dive in.

What Is “Accrued Revenue”?

Accrued revenue occurs when a company completes a service or delivers a product but hasn’t received payment for that product or service. Let’s use our lemonade stand as an example.

If we sell a glass of $1 lemonade to a customer that promises to pay us tomorrow, that’s $1 of accrued revenue. We’ve completed the task of delivering our goods to the customer. Now we wait for reimbursement.

Why does this happen? You can thank GAAP accounting. GAAP accounting states that a company must recognize revenue at the time it’s earned. Not when the company receives the cash.

This is an important distinction. Most companies perform services and provide goods without accepting the cash up front. Think of manufacturing companies. Usually these companies supply parts and widgets on a Net-30 basis.

In other words, the customer (who receives the widget) has 30 days to pay for that widget.

You might know accrued revenue as another name, accounts receivable.

Mechanics of Accrued Revenue on Financial Statements

Accrued revenue hits the financial statement in two ways: the balance sheet and income statement. As soon as a sale takes place, the company recognizes that sale as revenue on the income statement.

If we don’t receive cash at the point of sale, we have to also record an increase in the accounts receivables account on the balance sheet.

When the customer pays for the goods or service, we reduce that dollar amount on the accounts receivable account and increase the company’s cash amount on the balance sheet.

The Importance of Accrued Revenue

Understanding accrued revs is important because it offers us clues to the underlying health of a business. It allows us to spot cash-flow issues before they reach an earnings transcript or analyst write-up.

Remember: when in doubt, follow the cash

Here’s what you need to know about accrued revenue analysis:

    • Rising accrued revenues = bad sign
    • Shrinking accrued revenues = good sign

Rising accrued levels means the company’s having trouble collecting cash for goods and services it already performed.

Lower accrued revenues means the company’s collecting more cash from goods and services than it’s recording.

We want to buy businesses that reduce accrued revenues over time and avoid those that grow such balances. Doing so will save us a lot of money and stress over time.

If you have any questions feel free to reach out.

Related Posts

Subscribe To Our Newsletter

Brandon Beylo

Value Investor

Brandon has been a professional investor focusing on value for over 13 years, spending his time in small to micro-cap companies, spin-offs, SPACs, and deep value liquidation situations. Over time, he’s developed a deeper understanding for what deep-value investing actually means, and refined his philosophy to include any business trading at a wild discount to what he thinks its worth in 3-5 years.

Brandon has a tenacious passion for investing, broad-based learning, and business. He previously worked for several leading investment firms before joining the team at Macro Ops. He lives by the famous Munger mantra of trying to get a little smarter each day.

AK

Investing & Personal Finance

AK is the founder of Macro Ops and the host of Fallible.

He started out in corporate economics for a Fortune 50 company before moving to a long/short equity investment firm.

With Macro Ops focused primarily on institutional clients, AK moved to servicing new investors just starting their journey. He takes the professional research and education produced at Macro Ops and breaks it down for beginners. The goal is to help clients find the best solution for their investing needs through effective education.

Tyler Kling

Volatility & Options Trader

Former trade desk manager at $100+ million family office where he oversaw multiple traders and helped develop cutting edge quantitative strategies in the derivatives market.

He worked as a consultant to the family office’s in-house fund of funds in the areas of portfolio manager evaluation and capital allocation.

Certified in Quantitative Finance from the Fitch Learning Center in London, England where he studied under famous quants such as Paul Wilmott.

Alex Barrow

Macro Trader

Founder and head macro trader at Macro Ops. Alex joined the US Marine Corps on his 18th birthday just one month after the 9/11 terrorist attacks. He subsequently spent a decade in the military. Serving in various capacities from scout sniper to interrogator and counterintelligence specialist. Following his military service, he worked as a contract intelligence professional for a number of US agencies (from the DIA to FBI) with a focus on counterintelligence and terrorist financing. He also spent time consulting for a tech company that specialized in building analytic software for finance and intelligence analysis.

After leaving the field of intelligence he went to work at a global macro hedge fund. He’s been professionally involved in markets since 2005, has consulted with a number of the leading names in the hedge fund space, and now manages his own family office while running Macro Ops. He’s published over 300 white papers on complex financial and macroeconomic topics, writes regularly about investment/market trends, and frequently speaks at conferences on trading and investing.

Macro Ops is a market research firm geared toward professional and experienced retail traders and investors. Macro Ops’ research has been featured in Forbes, Marketwatch, Business Insider, and Real Vision as well as a number of other leading publications.

You can find out more about Alex on his LinkedIn account here and also find him on Twitter where he frequently shares his market research.